We were at the Cancer Congress

On 10 March to 11 March we participated in a congress at NH Prague City hotel on Hereditary breast and ovarian cancer - care for healthy individuals and mutation carriers. We were reminded of the importance of BRCA1/2 mutation for the treatment of other cancers or new trends and the future of genetic testing of cancer patients. We hope you stopped by our stand and we look forward to seeing you again.